270 related articles for article (PubMed ID: 15232720)
1. Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001.
Yust I; Fox Z; Burke M; Johnson A; Turner D; Mocroft A; Katlama C; Ledergerber B; Reiss P; Kirk O;
Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):550-9. PubMed ID: 15232720
[TBL] [Abstract][Full Text] [Related]
2. The incidence of cytomegalovirus (CMV) antigenemia and CMV disease is reduced by highly active antiretroviral therapy.
Varani S; Spezzacatena P; Manfredi R; Chiodo F; Mastroianni A; Ballarini P; Boschini A; Lazzarotto T; Landini MP
Eur J Epidemiol; 2000 May; 16(5):433-7. PubMed ID: 10997830
[TBL] [Abstract][Full Text] [Related]
3. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study.
Mitchell SM; Membrey WL; Youle MS; Obi A; Worrell S; Gazzard BG
Br J Ophthalmol; 1999 Jun; 83(6):652-5. PubMed ID: 10340970
[TBL] [Abstract][Full Text] [Related]
5. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis.
Martin BK; Ricks MO; Forman MS; Jabs DA;
Clin Infect Dis; 2007 Apr; 44(7):1001-8. PubMed ID: 17342657
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors.
Lin DY; Warren JF; Lazzeroni LC; Wolitz RA; Mansour SE
Retina; 2002 Jun; 22(3):268-77. PubMed ID: 12055458
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis.
Walmsley SL; Raboud J; Angel JB; Mazzulli T; Shen S; Casciaro L; Young CD; Moussa G; Gough K; Rachlis A; Hopkins J
HIV Clin Trials; 2006; 7(1):1-9. PubMed ID: 16632459
[TBL] [Abstract][Full Text] [Related]
8. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Whitcup SM; Fortin E; Lindblad AS; Griffiths P; Metcalf JA; Robinson MR; Manischewitz J; Baird B; Perry C; Kidd IM; Vrabec T; Davey RT; Falloon J; Walker RE; Kovacs JA; Lane HC; Nussenblatt RB; Smith J; Masur H; Polis MA
JAMA; 1999 Nov; 282(17):1633-7. PubMed ID: 10553789
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment.
Jabs DA; Van Natta ML; Holbrook JT; Kempen JH; Meinert CL; Davis MD;
Ophthalmology; 2007 Apr; 114(4):780-6. PubMed ID: 17258320
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Kedhar SR; Jabs DA
Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
[TBL] [Abstract][Full Text] [Related]
12. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.
Jouan M; Savès M; Tubiana R; Carcelain G; Cassoux N; Aubron-Olivier C; Fillet AM; Nciri M; Sénéchal B; Chêne G; Tural C; Lasry S; Autran B; Katlama C;
AIDS; 2001 Jan; 15(1):23-31. PubMed ID: 11192865
[TBL] [Abstract][Full Text] [Related]
13. Effect of highly active antiretroviral therapy on the incidence of HIV-related cytomegalovirus retinitis and retinal detachment.
Jalali S; Reed JB; Mizoguchi M; Flynn N; Gordon J; Morse LS
AIDS Patient Care STDS; 2000 Jul; 14(7):343-6. PubMed ID: 10935050
[TBL] [Abstract][Full Text] [Related]
14. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Sugar EA; Jabs DA; Ahuja A; Thorne JE; Danis RP; Meinert CL;
Am J Ophthalmol; 2012 Jun; 153(6):1016-24.e5. PubMed ID: 22310076
[TBL] [Abstract][Full Text] [Related]
15. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression.
Jabs DA; Van Natta ML; Thorne JE; Weinberg DV; Meredith TA; Kuppermann BD; Sepkowitz K; Li HK;
Ophthalmology; 2004 Dec; 111(12):2224-31. PubMed ID: 15582078
[TBL] [Abstract][Full Text] [Related]
16. The changing pattern of cytomegalovirus retinitis in human immunodeficiency virus disease.
Au Eong KG; Beatty S; Charles SJ
Singapore Med J; 2000 Jun; 41(6):298-300. PubMed ID: 11109349
[TBL] [Abstract][Full Text] [Related]
17. Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy.
Deayton JR; Wilson P; Sabin CA; Davey CC; Johnson MA; Emery VC; Griffiths PD
AIDS; 2000 Jun; 14(9):1163-70. PubMed ID: 10894280
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Jabs DA; Van Natta ML; Kempen JH; Reed Pavan P; Lim JI; Murphy RL; Hubbard LD
Am J Ophthalmol; 2002 Jan; 133(1):48-61. PubMed ID: 11755839
[TBL] [Abstract][Full Text] [Related]
19. Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
Gona P; Van Dyke RB; Williams PL; Dankner WM; Chernoff MC; Nachman SA; Seage GR
JAMA; 2006 Jul; 296(3):292-300. PubMed ID: 16849662
[TBL] [Abstract][Full Text] [Related]
20. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
